Daniel Martin Watterson
Works at
J.g. searle professor
Sources: reporter.nih.gov
Grants and prizes
UG3, STORM: Proof-of-concept STudies of ORal MW189, a novel anti-neuroinflammatory drug, in Alzheimer's patients, UG3AG104111, 2026–2028, 25 Aug 2026
U01, GMP Production and Extended Toxicology of an Oral Formulation Drug for Alzheimer's Disease, U01AG076480, 2022–2027, 26 May 2026
Sources: reporter.nih.gov